Learn More
Medchemexpress LLC 2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol | 1800340-40-2 | MFCD31544327 | 99.8% | 495.6 g/mol | C30H33N5O2 | 1 MG

Supplier: Medchemexpress LLC HY1015671MG
BMS-986158 (ezobresib) is an orally active small-molecule inhibitor of BET bromodomains used in oncology research. It binds the acetyl-lysine recognition pocket on BET proteins to disrupt chromatin-mediated transcription of oncogenes and has advanced into early clinical studies for hematologic and solid tumor indications.
- Potent cell-based activity (low-nanomolar IC50s in several cancer cell lines)
- BET bromodomain mechanism reduces expression of growth-promoting genes
- Demonstrated activity in small cell lung and triple-negative breast cancer models
- High chemical purity suitable for research applications
- Supplied in milligram quantities for preclinical experiments
- Chemical identifiers: CAS 1800340-40-2; formula C30H33N5O2
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.